News
 
NASSCOM begins milestone 20 edition of India Leadership Forum
India Infoline News Service/18:12,Feb 13, 2012
The core theme of NILF this year is 'hyperspecialization' and the platform promises to bring another exciting, thought provoking and insightful conference
list MindTree clarifies reports on growth outlook
list Dynamatic Technologies board declares 2nd Interim Dividend
list PR legend Tony Good bestowed with life time achievement award by PR Council of India
list Top IT news of the day

Calendar

Feb-2012
M T W T F S S
13 14 15 16 17 18 19
Economic Events
list QV House Prices (YoY)
list Food Prices (MoM)
Results
list CESC | Cipla | Ambuja Cem. | Castrol India
IPO
listNo IPO today
 

Wintac jumps 13% in two days on rights issue plan

Capital Market / 12:44 , Mar 12, 2010

Wintac advanced 2.87% to Rs 37.60 at 12:41 IST on BSE, extending gains for the second consecutive day, after the company said its board will meet on 18 March 2010 to consider the issue of equity shares on rights basis.

The stock had jumped 9.92% to Rs 36.55 on Thursday, 11 March 2010, after the company made this announcement after market hours on Wednesday, 10 March 2010.

Meanwhile, the BSE Sensex was up 11.64 points, or 0.07% to 17,179.60.

On BSE, 42,588 shares were traded in the counter as against an average daily volume of 1,792 shares in the past one quarter.

The stock hit a high of Rs 40.20 so far during the day, which is a 52-week high for the counter. The stock hit a low of Rs 36.60 so far during the day. The stock had hit a lifetime low of Rs 6.66 on 2 April 2009.

The stock has risen 13.08% in just two trading sessions from a recent low of Rs 33.25 on 10 March 2010.

The company's equity capital is Rs 4.55 crore. Face value per share is Rs 10.

The current price of Rs 37.60 discounts the company's Q3 December 2009 annualized EPS of Rs 2.56, by a PE multiple of 24.96.

Wintac reported net profit of Rs 0.29 crore in Q3 December 2009 compared to net loss of Rs 0.47 crore in Q3 December 2008. Net sales rose 20.4% to Rs 4.83 crore in Q3 December 2009 over Q3 December 2008.

The company produces a wide range of products in the pharmaceutical, fine chemical and agro chemical segments.

 



Rate This Article Rate 1 Rate 2 Rate 3 Rate 4 Rate 5
Average rating : 2.0